Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ)

por Hudgens, Stacie, Phillips-Beyer, Andrea, Newton, Louise, Seboek Kinter, Dalma, Benes, Heike
Publicado 2020

Preferences of patients for benefits and risks of insomnia medications using data elicited during two phase III clinical trials

por Heidenreich, Sebastian, Ross, Melissa, Chua, Gin Nie, Seboek Kinter, Dalma, Phillips-Beyer, Andrea
Publicado 2022

Number, Duration, and Distribution of Wake Bouts in Patients with Insomnia Disorder: Effect of Daridorexant and Zolpidem

por Di Marco, Tobias, Scammell, Thomas E., Meinel, Michael, Seboek Kinter, Dalma, Datta, Alexandre N., Zammit, Gary, Dauvilliers, Yves
Publicado 2023

Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled Trial

por Fietze, Ingo, Bassetti, Claudio L. A., Mayleben, David W., Pain, Scott, Seboek Kinter, Dalma, McCall, William V.
Publicado 2022

Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder

por Kunz, Dieter, Dauvilliers, Yves, Benes, Heike, García-Borreguero, Diego, Plazzi, Giuseppe, Seboek Kinter, Dalma, Coloma, Preciosa, Rausch, Magdalene, Sassi-Sayadi, Mouna, Thein, Stephen
Publicado 2022